| Type | Description |
|---|---|
| Definition | Scm like with four mbt domains 2 |
| Date | Results | Publications |
|---|---|---|
| 2021-01-02 12:53:00 | CircSFMBT2 facilitates vascular smooth muscle cell proliferation by targeting miR-331-3p/HDAC5. | 33166591 |
| 2019-12-14 10:12:00 | we revealed that SFMBT2 intervention by siRNA contributed to the catabolic phenotype of human chondrocytes mediated by NF-kB pathway. | 30133133 |
| 2019-03-02 10:34:00 | The present study identified Scmlike with four malignant brain tumor domains 2 (SFMBT2) as a novel regulator of SOX9 expression. | 30272322 |
| 2018-03-17 10:23:00 | Findings suggest that regulation of SFMBT2 may provide a new therapeutic strategy to control prostate cancer metastasis as well as being a potential biomarker of metastatic prostate cancer. | 27340776 |
| 2013-07-27 12:05:00 | SFMBT2 may regulate cell growth via epigenetic regulation of HOXB13 gene expression in prostate cancer cells. | 23385818 |
| Type | IDs |
|---|---|
| Gene |
UniProtKB-ID:
SMBT2_HUMAN
UniprotKB:
Q5VUG0
UniParc:
UPI00001C1EDF
EMBL:
CH471072,
AL590095,
AB046837,
BC152430,
AL139125,
AL138771,
AL158046
Ensembl:
ENSG00000198879
KO:
hsa:57713
|
| Nucleutide sequences |
EMBL-CDS:
AAI52431.1,
BAB13443.1,
EAW86385.1
Ensembl_TRS:
ENST00000361972,
ENST00000397167
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000380353,
ENSP00000355109
RefSeq:
NP_001374820.1,
NP_001374819.1,
NP_001374818.1,
XP_006717553.1,
NP_001025051.1,
NP_001018049.1
|
| Others |
UniRef100:
UniRef100_Q5VUG0
UniRef90:
UniRef90_Q5VUG0
UniRef50:
UniRef50_Q5VUG0
UniGene:
Hs.407983
CCDS:
CCDS31138.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员